New York Assembly bill in Session 2025-2026.
Status: in_committee. Latest action: January 7, 2026.
Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy.
Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.
| Date | Event | Detail |
|---|---|---|
| 2025-03-18 | Introduced | Bill introduced |
| 2026-01-07 | Status | in_committee |
| 2026-01-07 | Latest Action | In Assembly Committee |